Hedge Funds Are Dumping Dr. Reddy’s Laboratories Limited (ADR) (RDY)
To many of your fellow Dr.
Posts Tagged ‘Warner Chilcott Plc (WCRX)’
Eli Lilly & Co. (LLY), Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Where We’re Headed
Over the past couple of months we've discussed many of the biggest risk factors associated with some of the leading causes of death in the United States -- heart disease, cancer...
Hedge Funds Are Betting On United Therapeutics Corporation (UTHR)
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.
What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies.
Hedge Funds Are Crazy About Endo Health Solutions Inc (ENDP)
To many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Hedge Funds Are Betting On Warner Chilcott Plc (WCRX)
In today’s marketplace, there are tons of indicators investors can use to track the equity markets.
Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time.
Forest Laboratories, Inc. (FRX): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
If you were to ask many investors, hedge funds are seen as delayed, old financial tools of an era lost to time.
Taro Pharmaceutical Industries Ltd. (TARO): Insiders Aren’t Crazy About It
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds' portfolio at the end of March.
Warner Chilcott Plc (WCRX) & Actavis Inc (ACT): Can You Profit From This Pharma Tie-Up
Niche biotech company Warner Chilcott Plc (NASDAQ:WCRX) has been looking for an exit strategy ever since announcing strategic alternatives back in August 2012.
Warner Chilcott Plc (WCRX): Should You Buy Joel Greenblatt’s Latest Pick?
Searching for potential stock investments can be a daunting task.
Is United Therapeutics Corporation (UTHR) Going to Burn These Hedge Funds?
If you'd ask most investors, hedge funds are perceived as slow, old investment tools of the past.
Could Warner Chilcott Plc (WCRX) Receive a Higher Bid?
Recently, Actavis Inc (NYSE:ACT) announced that it would acquire Warner Chilcott Plc (NASDAQ:WCRX) for around $8.5 billion in total consideration.
Hedge Funds Are Betting On Warner Chilcott Plc (WCRX)
Is Warner Chilcott Plc (NASDAQ:WCRX) the right pick for your portfolio? The best stock pickers are turning bullish.
Warner Chilcott Plc (WCRX), Endo Health Solutions Inc (ENDP): An Undervalued Play in Pharma
Generic pharmaceutical manufacturer Actavis Inc (NYSE:ACT) made headlines after confirming that it has entered into early stage discussions with Ireland-based pharmaceutical...
Warner Chilcott Plc (WCRX) News: Actavis Inc (ACT) Update, £18 Million Gain & More
Generic drugmaker Actavis Inc (NYSE:ACT), itself the subject of takeover speculation, said on Monday it would buy specialty pharmaceutical company Warner Chilcott Plc (NASDAQ:...
Warner Chilcott Plc (WCRX), The Boeing Company (BA), Sequenom, Inc. (SQNM): Three Recent Upgrades You May Want to Ignore
An analyst’s upgrade almost always causes a stock to trend higher. However, those gains can often be a value-trap.
Warner Chilcott Plc (WCRX): Can Earnings Heal Its Woes?
Tomorrow, Warner Chilcott Plc (NASDAQ:WCRX) will release its latest quarterly results.
Is Actavis Inc (ACT) a Buy at This Price?
Actavis Inc (NYSE:ACT), the largest generic drug company in the US, just got even bigger.
Endo Health Solutions Inc (ENDP)’s Endgame
Endo Health Solutions Inc (NASDAQ:ENDP), a diversified healthcare company specializing in pain medication, has been sending out mixed signals recently.
The Most Trustworthy Drugs on the Market: Pfizer Inc. (PFE), Bayer AG (BAYN)
How much is trustworthiness actually worth? That somewhat strange thought entered my brain recently after reviewing the latest Harris Physician Pulse Survey.
Takeover Rumors Surround Endo Health Solutions Inc (ENDP)
Endo Health Solutions Inc (NASDAQ:ENDP) shares popped more than 17% last week on rumors of exploratory talks with potential buyers including Valeant Pharmaceuticals Intl Inc (...
